MEETING OF THE HIP SOCIETY
Twenty Seventh Open Scientific Meeting
The Fifth Combined Open Meeting Hip Society and AAHKS
HILTON HOTEL ANAHEIM CALIFORNIA C BALLROOM
SUNDAY, FEBRUARY 7, 1999
CONTENTS:
Program
Abstracts
Program:
COURSE DESCRIPTION:
This course is divided into six sections. The first debates the current
status of bearing surfaces, the second reports on infection, the third
discusses acetabular fixation in primary THA, the fourth presents
three award papers, the fifth revisits revision issues and the sixth
discusses THA in special cases.
COURSE OBJECTIVE:
The objective of this Open Meeting of the Hip Society is to provide
the participants with important information concerning current issues
in hip replacement surgery. The focus will be on optimum bearing surface
and other controversial issues in orthopaedic devices, the problem of
infection and a critical look at acetabular fixation as well as revision
issues and THA in special cases. It is hoped that this meeting will
provide the participants with a clear understanding of the present "state
of the science" of bearing surfaces and revision issues and that
it will introduce them to some new information regarding costs, grafting
and cementless and cemented revision as well as causes and treatment
of infection.
INTENDED AUDIENCE:
Orthopaedic surgeons and orthopaedic residents.
Program:
8:00 am
Welcome and Opening Remarks
Robert Bourne, M.D. -President, The Hip Society
Richard Rothman, M.D. -President, AAHKS
SYMPOSIUM I
CURRENT STATUS OF THE BEARING SURFACE DEBATE
Moderator: Seth Greenwald, Ph.D.
Cleveland Heights, OH
8:05 am
Sterilization and Packaging of Polyethylene
John Collier, DE
Hanover, NH
8:15 am
Assessment of Polyethylene Wear in Total Hip Replacement
A Review of Clinical Applications of the 3-D Technique
Peter DeVane, M.D.
New Zealand
8:25 am
The New Polyethylenes
Harry McKellop, Ph.D.
Los Angeles, CA
8:35 am
Metal on Metal
Dennis Bobyn, Ph.D.
Montreal, Quebec
8:45 am
Ceramic Bearing Surfaces
Harry Skinner, M.D.
Orange, CA
8:55 am
The Counterface, Surface Smoothness, Tolerances and
Coatings in Total Joint Prostheses
Seppo S. Santavirta, M.D.
Helsinki, Finland
9:05 am
Discussion
PRESIDENTIAL GUEST SPEAKER
9:20 am
Introduction of Orthopaedic Devices to the Marketplace
Henrik Malchau, M.D.
Goteborg, Sweden
SYMPOSIUM II
INFECTION
Moderator: Clive Duncan. M.D.
Vancouver, BC
9:40 am
Evidence Based Operating Room Environment
Merrill Ritter, M.D.
Mooresville, IN
9:50 am
New Organisms and New Antibiotics Associated
with Infected Total Hip Arthroplasty
Kevin Garvin, M.D.
Omaha, NE
10:00 am
The Use of Prophylactic Antimicrobial Agents During and After Hip Arthroplasty
Arlen Hannsen, M.D.
Rochester, MN
10:10 am
Infection: One-Stage vs. Two-Stage Exchange
John Callaghan, M.D.
Iowa City, IA
10:20 am
The Infected Hip Replacement: Management of the Complex Case
Clive Duncan, M.D.
Vancouver, BC
10:30 am
Discussion
10:45 am
Break
SYMPOSIUM III
ACETABULAR FIXATION IN PRIMARY THA
Moderator: Harry Rubash, M.D.
Boston, MA
11:00 am
Swedish Registry -The Acetabular Side
Henrik Malchau, M.D.
Goteborg, Sweden
11:08 am
Cemented All-Poly Socket Fixation in Total Hip
Chitranjan Ranawat, M.D.
New York, NY
11:16 am
The Optimal Cementless Metal-Backed Acetabular Component
Seth Greenwald, Ph.D.
Cleveland Heights, OH
11:24 am
Long-Term Results with Modular Cementless Acetabular Components
William Maloney, M.D.
St. Louis, MO
11:32 am
Fixation Strategies for Cementless Acetabular Cups
Michael D. Ries, M.D.
San Francisco, CA
11:40 am
Discussion
11:55 am
Lunch
SYMPOSIUM IV
THE AWARD PAPERS
Moderator: John Callaghan, M.D.
Iowa City, IA
1:00 pm
The Otto Aufranc Award
Wear and Lubrication of Metal-on-Metal Hip Implants
Frank W. Chan, Ph.D.
Montreal, Quebec
1:15 pm
The John Charnley Award
Practice Surveillance:
A Practical Method to Assess Outcome and to Perform Clinical Research
John J. Callaghan, M.D.
Iowa City, IA
1:30 pm
The Frank Stinchfield Award
Sudden Death During Primary Hip Arthroplasty
Javad Parvizi M.D.
Rochester, MN
1:45 pm
Frontiers of Orthopaedic Surgery
Richard Coutts, M.D.
San Diego, CA
SYMPOSIUM V
REVISION ISSUES
Moderator: Charles Engh, M.D.
Arlington, VA
2:00 pm
Cost Analysis of Revision Total Hip Arthroplasty:
A Five Year Follow-Up Study
Robert Barrack, M.D.
New Orleans, LA
Acetabular Revision:
2:10 pm
Cementless Acetabular Revision at 9-15 Years
Aaron Rosenberg, M.D.
Chicago, IL
2:18 pm
Acetabular Revision: The Role of Rings and Cages
Joe Schatzker, M.D.
Toronto, Ontario
2:26 pm
Restoration of Bone Stock for Revision Arthroplasty of the Acetabulum
Allan Gross, M.D.
Toronto, Ontario
Femoral Revision:
2:34 pm
Revision Hip Arthroplasty: The Femoral Side
Cecil Rorabeck, M.D.
London, Ontario
2:42 pm
Impaction Grafting
Graham Gie, M.D.
Exeter, UK
2:50 pm
Structural Grafting For Femoral Reconstruction
William Head, M.D.
Plano, TX
2:58 pm
Twenty Year Experience of Femoral Revision of Total Hip
Replacement using Second Generation Cementing Techniques
William Harris, M.D.
Boston, MA
3:06 pm
Cementless Femoral Revision
Wayne Paprosky, M.D.
Winfield, IL
3:14 pm
Discussion
3:35 pm
Break
SYMPOSIUM VI
THA IN SPECIAL CASES
Moderator: William Hozak, M.D.
Philadelphia, PA
3:50 pm
THA in Special Cases-DDH
William Capello, M.D.
Indianapolis, IN
3:58 pm
Single-Stage Bilateral Total Hip Arthroplasty
Paul Pellicci, M.D.
New York, NY
4:06 pm
Total Hip Arthroplasty in Paget's Disease
David Lewallen, M.D.
Rochester. MN
4:14 pm
Primary and Revision Total Hip Replacements in Jehovah's Witnesses
Carl Nelson, M.D.
Little Rock, AR
4:22 pm
Total Hip Arthroplasty for Hip Fractures
Miguel Cabanela, M.D.
Rochester, MN
4:30 pm
Total Hip Arthroplasty in Patients with Proximal Femoral Deformity
Daniel Berry, M.D.
Rochester, MN
4:38 pm
Discussion
5:00 pm
Adjourn
Robert Bourne, M.D.
London, Ontario
MEETING OF THE HIP SOCIETY
Twenty-Seventh Open Scientific
Meeting
Abstracts:
8:05
Sterilization and Packaging of Polyethylene
John P. Collier, D.E., Lauren
S. Bargmann, M.S., Brian C. Bargmann, M.S., Barbara H. Currier,
M.Ch.E.
Gamma sterilization in an air environment
can induce oxidation of polyethylene. This oxidation potentially
can lead to polyethylene embrittlement that compromises mechanical
integrity and clinical performance of polyethylene liners and inserts.
For these reasons, orthopaedic manufacturers have modified their
methods of sterilizing and packaging polyethylene. Information from
all major manufacturers suggests that they have moved away from
the potentially detrimental use of gamma irradiation in air. Two
alternative approaches have emerged: sterilization by non-radiation
methods and by gamma irradiation in inert environments. Liners and
inserts sterilized using alternative methods were tested to examine
material characteristics including oxidation level, mechanical properties,
and crosslink density. Data from liners and bearings shelf aged
up to 3 years following alternative sterilization techniques (both
non-radiation and gamma irradiation in an inert environment) exhibit
negligible oxidation, ductility above 400%, and ultimate tensile
strength near 50 MPa, all exceeding ASTM specifications. There are
significant differences in crosslink density depending on the sterilization
method. This study suggests that the shelf oxidation problem has
been addressed by these new sterilization techniques. However, long
term clinical performance and oxidation resistance must be evaluated
in the future.
8:15
Assessment of Polyethylene Wear in Total Hip
Replacement
A Review of Clinical Applications of the 3-D
Technique
Peter A. Devane, M.B.Ch.B., F.R.A.C.S.,
M.Sc.,
J. Geoffrey Home, M.B.Ch.B., F.R.A.C.S.,
M.Sc.
The 3-D technique is a new method
for the measurement of polyethylene wear in patients with total
hip joint replacement. Application of image processing technology
allows automation of point selection from digital images of radiographs
scanned into the computer. Validation of this new methodology reveals
a three-fold increase in accuracy and a forty-fold increase in reproducibility
compared to manual input of points from a digitizer in the bench
test situation. A review of 3-D technique application to clinical
patients gives new information on the factors which influence polyethylene
wear. Increasing age, activity level and femoral head size, as well
as decreasing polyethylene thickness and insertion of total hip
prostheses without cement, all increase polyethylene wear. Restoration
of femoral offset during total hip replacement appears to decrease
polyethylene wear. No demonstrable difference in polyethylene wear
rate could be found between two groups of patients, one with a stainless
steel-polyethylene articulation and the other with a ceramic-polyethylene
articulation. Measurement of the serial polyethylene wear of individual
patients reveals a high rate of femoral head penetration during
the first two years after total hip replacement using metal-backed
acetabular components inserted without cement. Interpretation of
this femoral head penetration as true polyethylene wear may be erroneous,
however, since creep of the polyethylene and acetabular liner movement
within its metal shell cannot be measured.
8:25
The New Polyethylenes
Harry A. McKellop, Ph.D.
Extensive research has shown that crosslinking of
UHMW polyethylene acetabular cups improves their wear resistance.
Traditional radiation sterilization in air crosslinks the polyethylene,
but also initiates immediate and long-term oxidative degradation
of the wear resistance and other physical properties. Consequently,
while some manufacturers advocate non-irradiation sterilization
(Et-O or gas plasma), others continue to sterilize with gamma radiation
to crosslink the polymer, but with the components scaled in a low
oxygen packet. While the immediate result is less oxidation, and
a lower wear rate than for non-irradiated polyethylene, laboratory
tests have shown that the free radicals remaining in the irradiated
polyethylene can oxidize over time, substantially increasing the
wear rate. To retain the advantages of crosslinking without oxidation,
extruded bars of UHMW polyethylene can be irradiated and then heated,
e.g., overnight, to extinguish the residual free radicals. The oxidized
surface of the bar is removed during machining of the cup, providing
a crosslinked polyethylene that is very resistant to long-term oxidative
degradation. If the radiation (crosslinking) dose is increased to
2-3 times the maximum used for sterilization, wear is reduced to
an undetectable level, but this must be balanced against reductions
in tensile strength and elongation that accompany the crosslinking.
8:35
Metal On Metal
J.D. Bobyn, Ph.D., J.B. Medley,
Ph.D., F.W. Chan, Ph.D., S. Yue, Ph.D.
Metal-metal hip bearings have traditionally
been fabricated from surgical grade cobalt-chromium-molybdenum alloys
(Co-Cr-Mo) because of their corrosion and wear resistance. Many
of the original metal-metal implants such as the McKee-Farrar experienced
problems with early loosening because of poor design and manufacture
leading to equatorial seizing and high frictional torque. The central
issue of wear, however, was not a cause of failure. As self-bearing
materials, Co-Cr-Mo alloys are highly resistant to runaway wear,
more so than self-bearing ceramics. First generation metal-metal
devices that have survived out to two decades or longer are characterized
by low wear rates and small changes in dimensions and surface finish.
Metal-metal articulations are currently
witnessing a renaissance in several countries worldwide. More than
60,000 Sulzer metal-metal hips have been implanted since 1988. Several
US companies, most notably Johnson & Johnson, Biomet, Depuy
and Wright Medical Technology have developed implants for clinical
trials. There is consensus that the femoral head should be smaller
than the acetabular cup to ensure polar bearing and provide clearance
for the ingress of lubricating fluids. Diametral clearances for
28 mm second generation clinical devices are generally held within
the 50 to 100 micrometer range. Hip simulator studies have demonstrated
the importance of tight control over dimensions, sphericity, and
surface roughness. With high manufacturing quality, wear volumes
of <1mm3 after several million wear test cycles can
reproducibly be obtained. The typical wear response is characterized
by an early period of run-in wear followed by a more steady-state
period of distinctly lower wear. One of the advantages of improved
bearing technology is the ability to use larger head/cup sizes without
large increases in wear volumes. This can lead to improved range
of motion, less impingement, and the use of very large implant sizes
as required for surface replacement of the hip.
Retrieval analyses of modern total
hip devices have indicated very low linear wear rates of 1-5 micrometers/year.
The most likely explanation for this behaviour is elastohydrodynamic
lubrication, combined with effective boundary lubrication and a
wear-resistant microstructure. Theoretical predictions of lubricant
film thickness using numerical models of elastohydrodynamic lubrication
have indicated that complete protection of the metal surfaces during
articulation can occur with the right clearance and surface roughness.
There is currently no consensus on which Co-Cr-Mo alloy is preferred
for self-bearing applications with the cast alloy, high carbon wrought
alloy, and low carbon wrought alloys all presently in clinical use.
Characterization of the wear surfaces
of simulator-tested metal-metal implants by scanning electron microscopy
and atomic force microscopy has revealed several interesting features.
This includes the changing morphology of alloy carbides with increasing
simulator test cycles, the formation of micropits at carbide sites
and within the alloy matrix, the removal of matrix material through
a delamination type of process, and the finding of residual material
from the grinding and polishing phases of manufacturing that could
act as third-body abrasives. Further microscopic study of the subtle
changes that occur at the articulating implant surfaces at long
cycle intervals is required to elucidate their role in overall wear
resistance and any advantages of one alloy type over another.
Preliminary indications are that
metal-metal wear particles are in the 20-60 nm size range, about
an order of magnitude smaller than polyethylene wear particles produced
in conventional metal-polyethylene articulations. Thus, very small
volumetric wear can equate to a very large number of individual
particles possessing a very high surface area. This raises questions
about mechanisms of macrophage-mediated osteolysis and the importance
of particle size, particle area, and particle chemistry in causing
bone resorption. Of important note from a clinical standpoint is
that 20-30 year Ring metal-metal hip prostheses implanted without
bone cement are notable by their absence of peri-implant osteolysis.
Issues of cytotoxicity and the long-term local and systemic tissue
response to the various Co-Cr-Mo alloy elements require further
study and definition.
With all metal-metal hip implants
there exists the important issue of integrating the acetabular bearing
surface into the overall cup design. The current approaches include
molding the bearing surface directly into a polyethylene insert
or avoiding polyethylene altogether by connecting the acetabular
bearing directly into the metal backing with a large taper-lock.
Both approaches involve modularity and therefore need to be carefully
studied for mechanical stability and potential for fretting motion.
Also important to consider is femoral neck impingement against the
acetabular liner. This problem is aggravated by cup malposition
and could cause neck notching and metal release, particularly with
titanium alloy stems. Close attention to design detail and manufacturing
quality must be supplemented with rigorous mechanical testing and
hip simulator studies under aggressive loading conditions so that
the limitations of the technology are fully understood. The potential
for greatly reduced wear and problems with osteolysis clearly exists
with metal-metal hip implant technology. Controlled clinical studies
should probably be completed prior to consideration for general
use.
8:45
Ceramic Bearing Surfaces
Harry B. Skinner, M.D., Ph.D.
Despite more than 25 years of clinical experience
with ceramic materials as bearing surfaces, their role in modern
joint replacement surgery remains to be clearly defined. The two
primary materials are alumina and zirconia; both are oxides, of
aluminum and zirconium, respectively, in their highest oxidation
state. The application of these materials is primarily as a femoral
head bearing surface against polyethylene, but alumina is also used
as both femoral head and acetabulum to provide a polyethylene-free
bearing surface. These materials represent a typical cost (risk)/benefit
trade-off. The advantages or benefits are biocompatibility, hardness,
wetability, strength, ability to obtain good surface finishes, probable
low wear of either ceramic against polyethylene, and for alumina,
low wear against alumina. Linear polyethylene wear against alumina
heads is reported to be as much as a factor of 5 to 10 lower than
metal vs. polyethylene. Thus, the ceramic femoral head may be a
good choice for the younger patient where it seems necessary to
use a 32mm head for stability reasons, although supporting data
are sparse. The disadvantages are cost, limited head-neck sizes
due to strength limitations, potential for fracture, and occasional
high alumina-on-alumina wear. Many of the problems of the past have
been design, manufacture, or application related, and have been
improved or eliminated. Proper clinical technique in the use of
ceramic femoral heads is crucial to preventing fracture and alumina-on-alumina
wear is an order of magnitude lower than ceramic-on-polyethylene.
The materials hold high promise and should continue to be used so
that further experience can help define the clinical indications
for components made of these materials.
8:55
The Counterface, Surface Smoothness, Tolerances
and Coatings in Total Joint Prostheses
Seppo S. Santavirta, M.D., Rello
Lappalainen, Ph.D., Asko Anttils, Ph.D.
and Panu Pekko, M.Sc.
Surface finish and tolerances of contact surfaces
are important in tribology of bearing surfaces in total joint prostheses.
Low friction and wear are desirable characteristics to be reached
by using proper counterface material combinations and macro- and
microgeometry of loading surfaces. In metal/polyethylene and ceramic/polyethylene
pairs, the counterfaces match by the elasticity and wear of polyethylene.
Although friction is low (coefficient of friction 0.05-0.10), the
wear rate of polyethylene remains high compared to metal-metal pairs
even with optimized surface geometries and head sizes of hip joint
prostheses. The wear is increased by hard third body particles,
e.g.methylmethacrylate debris. In hard counterface pairs (metal-metal,
ceramic-ceramic), low friction and wear rates should be achieved
with continuous lubricating fluid film formed if the head-cup tolerances
are about a few ten micrometers. Based on clinical surveys, in most
total hip prostheses continuous film lubrication has not been achieved
and the clearance does not seem to have an accurate optimal value.
In practice, sliding surfaces are in contact at the surface asperities.
Local high surface pressures lead to high wear and friction. In
principle, low wear rates should be achieved using hard coatings
or bulk materials. Diamond is a novel coating material with many
superior, desired characteristics such as low friction, high wear
and corrosion resistance and well bonding surface to bone. Currently,
there is a large variability in tolerances, surface finish and materials
quality of commercially available total hip prostheses, leading
to differences in friction and durability.
9:20
Introduction of Orthopaedic Devices to the
Marketplace
Henrik Malchau, M.D.
Introduction.
Decisions about medical treatment should be based on a careful appraisal
of the best evidence available. In order to increase evidence –based
decision making in the evaluation of new surgical techniques and
implants a stepwise introduction is necessary to expose as few patients
as possible to the risk of failure.
The history of development of total
hip arthroplasty could have been different if the introduction had
been more careful and performed in a stepwise manner. Inferior properties
would have been revealed earlier thus reducing the number of failures
and allowing the necessary improvements. It is therefore desirable
that the profession agree on a standardised way to introduce new
implants. Based on the Swedish experience the following schedule
for stepwise clinical introduction of new implants is suggested.
The initial step is a preclinical
testing beyond the scope of this paper.
The first clinical step is
the open prospective and preferably randomised trial including a
minimum of patients to obtain a valid evaluation. The strict rules
of prospective randomised trials should be addressed. In this first
clinical level high accuracy methods such as radiostereometric analysis
(RSA) and dualenergy x-ray absorptiometry (DEXA) are required. Within
6 months to 2 years these methods have the potential of identifying
implants with inferior/superior fixation, extreme wear or unfavourable/favourable
bone remodelling. Results from these methods determine if further
clinical evaluation is worth while. It should be noted and underlined
that all types of complication cannot be predicted and further follow
up is necessary and should be done.
If migration analysis is performed
with conventional methods (less accurate than RSA) larger cohorts
is needed, exposing more patients for potential risks.
Step 2. If favourable results
are obtained in step 1, the second step, a multi-center trial exposing
the new procedure to a broader aspect of the orthopaedic community
can be initiated. The implant will then be exposed to various surgical
techniques and hospital environments. In Step 1 investigations there
is a risk for susceptibility and performance bias as the inventors
often perform this first introductory investigations. The protocol
of the multi-center study must be carefully prepared and agreed
upon by all participating inventors. A sufficient number of patients
must be included in order to allow statistical analysis. The witnessed
or written patient consent is essential, as is an approval by ethical
committee. The ultimate goal will be to make even the multi-center
trial randomised using a well-documented implant as the golden standard
on baseline control.
Step 3 in the evaluation is a continuous
quality control effected by register studies based on large population
to reveal early or unusual and potential catastrophic complications.
In a comparable small community as Sweden the register should be
nation-wide and include all units in a specific field.
9:40
Evidence Based Operating Room Environment
Merrill A. Ritter, M.D.
To control the source of environmental contamination
and hopefully sepsis following total joint replacement surgery one
must realize that man is the source of the bacteria as evidenced
by a rise in colony forming units per square foot per hour from
13 to 400 when they are absent or present respectively. The use
of inclusive gowning is helpful. Face masks and head covers offer
no environmental protection. Some type of an environmental control,
such as laminar air flow or ultraviolet light is the most helpful
with over a 90% reduction at the wound and 60% reduction in the
operating room itself.
9:50
New Organisms and New Antibiotics Associated
With Infected Total Hip Arthroplasty
Kevin L. Garvin, MA, Craig R.
Mahoney, M.D., and Joshua A. Urban, M.D.
Introduction: Infection
after total hip replacement can be managed successfully in approximately
90% of patients. This high rate of success is potentially at risk
because of the emergence of resistant bacteria and our failure to
identify new antibiotics to treat these pathogens.
Materials, Methods and Results: Since January
1991, 62 total joints of the hip or knee in 59 patients were treated
for infection. Forty-six (75%) of these joints were infected with
gram positive bacteria and 15 (25%) were methicillin or oxacillin
resistant Staphylococcus aureus or coagulase-negative Staphylococcus.
Vancomycin resistant organisms (Enterococcus and Staphylococcus)
were not identified in this group of patients. Thirty-two of the
joints were hips and 25 of the prostheses have been retained or
reimplanted. At an average follow-up of 3.3 years, all of the patients
are still free of infection. The remaining seven patients have not
been reimplanted at the time of this writing.
Discussion: Although, vancomycin resistant
bacteria were not identified in our series of patients these bacteria
have involved orthopaedic patients elsewhere. The use of Vancomycin
is clearly a risk factor for the emergence of these resistant bacteria
and injudicious use is discouraged. The role of new antibiotics
(Synercid, Linezoilid, Teicoplanin and Trovafloxacin) in the treatment
of these patients has not been established.
10:00
The Use of Prophylactic Antimicrobial Agents
During and After Hip Arthroplasty
Arlen D. Hanssen, M.D. and Douglas
R. Osmon, M.D.
An intravenous antibiotic, just prior to skin incision,
effectively reduces the prevalence deep wound infection. Controversies
include selection of the optimal antibiotic, appropriate timing,
and proper duration of prophylaxis. Currently, a short duration
of prophylaxis is recommended. Considerations of the efficacy, cost,
and toxicity need to be individualized based on the susceptibility
patterns of microorganisms causing prosthetic infection within the
practitioners' institution. Institutional antimicrobial compliance
strategies are cost-effective and improve the timing of antibiotic
administration. Awareness and compliance with published antimicrobial
restriction recommendations is warranted due to the concern of emerging
antibiotic resistant bacteria. Specifically, restriction of vancomycin
in orthopaedic surgery should be critically targeted.
Supplemental antibiotic administration during the
intraoperative period includes additional antibiotic dosing, use
of antibiotic-irrigant solutions, and admixture of antibiotics into
acrylic bone cement or bone graft. Experimental efforts are actively
underway to evaluate antibiotic-laden surface coating of implants.
There are no established standards or clinical guidelines for these
supplemental antibiotic applications. Postoperatively, antimicrobial
agents are frequently overused for a variety of clinical scenarios
and this pattern of antibiotic usage is potentially detrimental.
A prophylactic antimicrobial strategy for prevention
of early and late hematogenous infection requires deliberation of
host risk factors, wound environment variables, and sources of potential
bacteremia as well as the cost-effectiveness, efficacy, and complications
associated with routine use of antibiotics. Significant efforts
are underway by expert panels to provide advisory statements for
elective procedures, which may potentially cause bacteremia. Additional
research is required to provide data for this area of antimicrobial
agent prophylaxis.
10:10
Infection: One Stage vs. Two Stage Exchange
John J. Callaghan, M.D., Ralph
P. Katz, M.D., Richard C. Johnston, M.D.
With the initial poor results reported with the
treatment of infection of total hip arthroplasties in North America,
two-stage exchange became the preferred treatment. However the morbidity
and the cost of the staged procedure as well as the encouraging
reports of direct exchange in Europe and the United States have
led some surgeons to reconsider direct exchange. Below are the reports
of one and two stage exchange procedures
TABLE 1. Comparison of One-and
Two-Stage Exchanges
One stage Two stages
Author No. of hips Success % No. of hips
Success %
Cement with antibiotics
Buchholz 667 77.0 --- --
Lindberg 59 90.0 18 78.0
Murray 13 38.5 22 95.5
Turner 101 86.0 --- --
Wroblewski 102 91.0 --- --
Hope 72 87.5 19 100.0
Elson 235 87.5 61 96.5
Garvin 21 90.5 55 92.7
Duncan --- --- 46 93.0
Sanzen 72 76.0 30 74.6
Rant 57 86.0 --- --
Miley 47 87.0 --- --
Ure 20 100.0 --- --
Present study 24 91.7 --- --
Cement without antibiotics
Hunter 55 18.0 10 60.0
Talbott --- --- 25 80.0
Cherney and Amstutz 5 80.0 28 64.0
Fitzgerald --- --- 111 90.0
Jupiter 18 78.1 --- --
Salvati 31 91.0 28 89.0
Callaghan 14 86.0 18 94.5
McDonald --- --- 82 86.6
Lieberman --- --- 32 91.0
Hughes 13 92.3 13 84.6
Although we continue to perform staged reimplantation
in younger patients, patients with virulent organisms, host compromised
patients and patients with poor bone quality we consider direct
exchange in older patients, with sensitive organisms and good bone
quality.
10:20
The Infected Hip Replacement:
Management of the Complex Case
Clive P. Duncan, M.D.
Complexity is introduced under a number of circumstances
when dealing with infection after hip joint replacement. These may
relate to the organism (MRSA, VRE, Polyclonal Infection), to patient
behaviour (intravenous drug use, alcoholism), to general health
(immune compromise) or to the local anatomy (substantial soft tissue
or bone loss). This paper will deal with management of the latter:
deep-seated infection associated with segmental bone loss of the
femur.
This is a relatively uncommon but challenging problem,
which requires a two-stage approach to management: removal of all
foreign material and resection of devitalized tissue in the first
stage; followed by complex reconstruction at the second stage. Typically
this problem presents against a background of multiple previous
operations (multiple revisions, periprosthetic fractures) or following
substantial resection of bone at the index procedure for the management
of a tumor.
The principles of management are similar to the
straightforward case and include: identification of the organism
and its antibiotic sensitivity profile, adequate imaging to define
the location and extent of foreign material (standard radiographs,
full-length views of femur, Judet views of pelvis), extensile exposure
of the hip and femur without further devascularization of bone,
removal of the implant and all cement (with intraoperative imaging
if necessary), and consideration of an antibiotic-loaded depot.
The second stage is usually more challenging than the straightforward
case, as bone stock must be replaced (substantial allograft, special
prostheses) and the risk of instability needs special consideration.
Furthermore, in the interval between the two stages,
in the face of substantial proximal femoral bone loss, there is
the unique difficulty of managing the hip, the limb and the patient
in a manner that will maintain reasonable limb length, promote mobilization
and permit discharge from hospital. It was for this purpose that
the PROSTALAC principle (PROSTheses of Antibiotic
Loaded Acrylic Cement) was developed in 1986.
Its purpose was to substitute for missing or resected bone, using
a facsimile of the hip and femur made of antibiotic-selective PMMA
over an endoskeleton of metal. The system has been refined over
the years, to the point where it is an intraoperative custom-made,
immediate fit, antibiotic-selective prosthesis, quite adaptable
to a wide range of difficult problems. It maintains the length of
the limb, motion of the joint, mobility of the patient with protected
weight bearing and it leads to a high dose of periprosthetic antibiotic
in the infected surgical bed.
This principle has been applied in more than forty
complex cases to date. Thirty of these were recently studied, with
an average duration of follow up measuring four years (range 2-10
years). The organisms were Gram-positive in 23, Gram-negative in
6 and M tuberculosis in one. The antibiotics used were based
on the sensitivities of the organisms identified and included a
combination of Tobramycin and Vancomycin in 23 cases, Vancomycin
alone in 3, Tobramycin and Penicillin in 3, and Streptomycin in
the single patient with micobacterial infection. Antibiotics were
continued for six weeks after operation. The average duration between
stages was twelve weeks and the type of reconstruction at the second
stage was based on the requirements to achieve a stable construct.
At the time of follow up (minimum 2 years, average
4) infection had recurred in only one patient (3.3%): 12 months
after the second stage, due to a different organism. That case was
successfully managed with another two-stage protocol using a PROSTALAC
in the interval again.
11:08
Cemented All-Poly Socket Fixation in Total
Hip
C.S. Ranawat, M.D.
The ideal bone implant bond should be easy to achieve,
reproducible, should provide good pain relief and function, be durable,
and without local or systemic ill effect. Thus far, no method of
fixation meets all these requirements.
The reported clinical failure rate of socket fixation
is less than 5% for 10-15 years follow-up. The radiographic failure
rate using global radiolucency and migration of 3 mm as criteria
is around 25% (Wrobleski). The primary reason for early septic loosening,
i.e. within 10 years, is due to failure to achieve good micro and
macro interlock at the time of surgery. The interface failure secondary
to histolytic invasion occurs with longer follow-up.
MODERN CEMENT TECHNIQUE
Modern cement technique improves the radiographic
appearance (Ranawat et al 1988). This can be further improved by
hypotensive epidural anesthesia (Ranawat et al 1990). With the improved
cement technique, clinical and radiographic loosening of bone cement
interface was 7.2%, with an average follow-up of 9.5 years (Ranawat
et al 1995). This includes 0.8% clinical failure rate and 3% radiographic
migration and 3.4% of progressive global radiolucency. We believe
that the state of bone cement interface, as seen in the early postoperative
radiograph, can predict the longevity of the cemented socket to
a high degree of probability.
PATIENT SELECTION
We continue to use cemented all-poly sockets for
patients who are 60 years old or older, whose life expectancy is
estimated to be 15-20 years longer. A cemented polyethylene socket
is not advised in the presence of excessive bleeding and in dysplastic
or rheumatoid patients.
In summary, fixation of all-poly cemented socket
is reproducible and provides excellent hip function for 10 years
and longer. The results are comparable with noncemented sockets
for 10 years. With noncemented fixation, increase of poly wear and
osteolysis are emerging concerns.
11:16
The Optimal Cementless Metal-Backed Acetabular
Component
A. Seth Greenwald, Ph.D.
Metal-backed polyethylene cups have
gained widespread use in total hip arthroplasty and are advocated
for both cementless and hybrid application. Continued optimization
of mechanical design and surgical technique has diminished the frequency
of short-term failure of these systems with attention now focused
on long-term survivorship. Locking mechanism integrity, cup/liner
conformity, polymer material characteristics, machining tolerances,
surface finish and the inclusion of holes are design factors which
influence the in vivo service life of these components. A
series of ongoing laboratory experiments to evaluate the influence
of these factors on in vivo implant performance are described.
Bench-top evaluations of sixteen metal-backed cup systems particular
to their locking mechanism integrity indicate a range of lever-out
strength, 43 in-lbf to 890 in-lbf, while cup/liner conformity was
found to vary between 3% and 96% of the available polyethylene surface
area. The influence of these findings as affecting implant instability
and the potential for debris generation, which leads to an osteolytic
response, are discussed. Evolving optimization of metal-backed cup
design attempts to accommodate the extended in vivo service
life demands of younger, more active patients as well as the extended
longevity of our senior population.
11:24
Long-Term Results With
Modular Cementless Acetabular Components
William J. Maloney, M.D., Michael
Anderson, M.D., Joshua J. Jacobs, M.D., Jorge O. Galante, M.D.,
Paul Lachiewicz, M.D., Harry Rubash, M.D.,
Steve Schutzer, M.D., Steven T.
Woolson, M.D., William H. Harris, M.D.
Cementless porous coated acetabular components have
essentially replaced cemented sockets for both primary and revision
surgery in North America. We are now reaching a point in terms of
length of follow-up that we can begin to critically examine the
implications of that choice. A multicenter review was performed
analyzing the radiographic results of more than 1000 cementless,
hemispherical porous-coated, first generation acetabular components
(Harris/Galante 1, Zimmer, Warsaw, IN). All components were inserted
with a line to line reaming technique using screws to provide implant
stability.
Radiographic analysis consisted of an evaluation
of implant stability documenting implant bone interface radiolucency,
cup migration or a change in cup position. Osteolysis, screw breakage
and porous coating fragmentation were recorded. Polyethylene wear
was measured. Patients were followed for a minimum of five years
with a maximum follow-up of twelve years. Specific attention was
given to patients less than 50 years of age at the time of their
index operation.
Overall, linear polyethylene wear averaged 0.11
millimeters per year (range: 0 to 0.86 mm/year). Two sockets were
revised for aseptic loosening. One case of aseptic loosening was
in a pelvis with radiation necrosis and the second had polyethylene
and pelvic osteolysis. The second patient had a MVA with associated
pelvic fracture. Three additional sockets had migrated. Two of these
patients had pelvic radiation. . Pelvic osteolysis was noted in
2.3 % of cases. Patients who were fifty or less at the time of their
index operation had a higher rate of pelvic osteolysis.
Over the time period of this study, the Harris-Galante
acetabular component has proven reliable in terms of both clinical
performance and radiographic stability. Measured polyethylene wear
in this study is comparable to what has been previously reported
with all polyethylene cemented sockets. To date, pelvic osteolysis
has not been a major problem, but continued follow-up is required
as the prevalence of the problem is likely to increase with time.
Screw fixation does not predispose to pelvic osteolysis.
11:32
Fixation Strategies for Cementless Acetabular
Cups
Michael D. Ries, M.D., Abraham
Salehi, Ph.D., Jeff Shea, B.S.
Initial stability of oversized press
fit acetabular cups is achieved when periacetabular bone strains
are concentrated at the periphery of the cup. Stability can also
be achieved with supplemental screws, spikes or fins. In this study,
periacetabular strains produced by different cementless acetabular
cup geometries were compared using an axisymmetric photoelastic
model. The cup geometries consisted of tri-spiked, finned, oversized
hemispherical, and non-hemispherical (wider than a hemisphere at
the periphery) geometries. The cup models were incrementally loaded
in the photoelastic material. The peripheral strain distributions
and their magnitudes induced by the tri-spiked, and oversized hemispherical
cups were similar, but the tri-spiked cup induced localized high
strain regions where the spikes penetrate the bone model. The added
feature (spikes) increased the force to seat the cup. Use of spikes
for fixation may be most appropriate when the spikes do not prevent
complete cup seating. The fins cut the periacetabular material into
quadrants, which decreased the peripheral strains. This cup produced
the least amount of press fit strain near the rim. A geometry with
a wider diameter at the rim than a hemisphere increased peripheral
strains more than an oversized hemispherical geometry and required
less force to seat the implant.
1:00
The Otto Aufranc Award
Wear and Lubrication of Metal-on-Metal Hip
Implants
Frank W. Chan, Ph.D., J. Dennis
Bobyn, Ph.D., John B. Medley, Ph.D.,
Jan J. Krygier, CET and Michael
Tanzer, M.D.
The implication of polyethylene wear particles as
the dominant cause of periprosthetic osteolysis has created a resurgence
of interest in metal-on-metal implants for total hip arthroplasty
because of their potential for improved wear performance. Twenty-two
cobalt chromium molybdenum metal-on-metal implants were custom manufactured
and tested in a hip simulator. Accelerated wear occurred within
the first million cycles followed by a marked decrease in wear rate
to low steady state values. The volumetric wear at three million
cycles was very small, ranging from 0.15 to 2.56 mm³
for all implants tested. Larger head-cup clearance and increased
surface roughness were associated with increased wear. Implant wear
decreased with increasing lambda ratio, a parameter used to relate
lubricant film thickness to surface roughness, suggesting some degree
of fluid film lubrication during testing. This study provided important
insight into the design and engineering parameters that control
the wear behavior of metal-on-metal hip implants and indicated that
high quality manufacturing can reproducibly lead to very low wear.
1:15
The John Charnley Award
Practice Surveillance: A Practical Method
to Assess Outcome
and to Perform Clinical Research
John J. Callaghan, M.D., Richard
C. Johnston, M.D.,
Douglas R. Pedersen, Ph.D.
The senior author began systematically collecting
preoperative and postoperative data on all the total hip arthroplasties
he performed starting in July of 1970. The data collected represents
a twenty-six year experience using practice surveillance (preoperative
and regular interval postoperative collection and analysis of outcomes)
as a method to document the outcome of the total hip arthroplasty
procedure and as a method to evaluate the need for changes in the
procedure based on this practice surveillance. As the senior author
made few selected changes in the operative procedure over the follow-up
period, the primary author has been able to evaluate the change
in outcome based on these changes. The six studies reported in this
manuscript demonstrate the durability of the long term results of
cemented total hip arthroplasty, the improvement in radiographic
reproducibility obtained on the femoral side of the construct with
improved cementing techniques, the deleterious effects of using
cable to reattach the greater trochanter, the deleterious effects
of changing femoral component design which included a change in
surface finish, the improvement in acetabular fixation using cementless
fixation, and the optimization of bearing surface wear using smaller
diameter femoral heads. All of these findings have been incorporated
into the primary surgeon's practice today based on this practice
surveillance. As demonstrated, practice surveillance has also provided
a tool for performing clinical research. Although practice surveillance
of controlled cohorts will never supplant prospective randomized
clinical trials in evidence based medicine it should help each individual
surgeon with his or her own practice and can be used as an important
research tool to study the optimization of outcomes of a surgical
procedure.
1:30
The Frank Stinchfield Award
Sudden Death During Primary Hip Arthroplasty
Javad Parvizi M.D., Allan D. Holiday
M.D., Mark H. Ereth M.D.,
David G. Lewallen, M.D.
Intraoperative hip arthroplasty deaths between 1969
and 1997 were reviewed and compared to Total Joint Registry data
on all arthroplasties. Mortality cases were reviewed in detail along
with autopsy findings. Practice changes in 1988 aimed at minimizing
fat embolization in high-risk patients prompted comparison of patients
before and after 1988. Those changes included noncemented implant
use in some and avoidance of pressurization and canal plugging,
or drill holes to vent the femur above a plug, in others considered
at risk.
Results: 23 deaths occurred in 38,488
arthroplasties (0.06%). All deaths occurred among 14,469 cemented
primary arthroplasties (0.159%). No deaths occurred during 15,411
noncemented arthroplasties, or during 8,608 revisions, 18/23 had
a fracture diagnosis (4 pathological). 21/23 had known cardiovascular
disease. Incidence of death for fracture cases was 5 times that
for non-fracture cases (0.30% vs. 0.06%) (p<0.03). Incidence
of death for all arthroplasty patients between 1969 and 1988 was
19/21,895 (0.087%) vs. 4/16,593 (0.024%) after 1988, a greater than
threefold difference (p< .05). This reduction was due to a greater
than fivefold difference in mortality among acute fracture patients
receiving a cemented implant after 1988 (p < .05) and the elimination
of deaths among 2,138 selective cemented arthroplasties. After that
date, versus 5/6,364 (0.08%) between 1969 and 1988 (p < .05).
Autopsy in 13 showed pulmonary fat and marrow microemboli (11/13)
and methacrylate particles (3/13).
Conclusion: Elderly patients with
pre-existent cardiovascular conditions, undergoing cemented arthroplasty,
especially for fractures, are at increased risk for intraoperative
death compared to elective patients. Altering patient implant selection
and using techniques designed to minimize intramedullary hypertension
in at risk patients can produce significant reductions in intraoperative
mortality.
2:00
Cost Analysis of Revision Total Hip Arthroplasty:
A Five Year Follow-Up Study
Robert L. Barrack, M.D., Jaswin
Sawhney, M.D., Joseph Hsu, M.D.,
Robert H. Cofield, M.H.A.
Introduction: A
study was undertaken to determine the resources required of the
surgeon and the hospital in performing revision total hip arthroplasty
(THA). Results were compared between 1990-1992 and 1995-1997 to
determine if any changes had occurred over that five year span.
Methods: A stratified, unselected
sample of thirty revision THAs performed between 1990-1992 in which
complete clinical and financial data was available was studied.
Clinical data included age, sex, diagnosis, length of stay (LOS),
operative time and blood loss. Financial data included cost of implants,
bone graft and accessories, hospital charge and surgeon reimbursement.
Results were compared to an analogous group of fifty revision THAs
performed at the same institution between 1995-1997. Cases were
classified as simple (involving revision of only acetabular liner
and/or femoral head), routine (revision of acetabular and/or femoral
components) or complex (major structural graft, antiprotrusio cage,
impacted grafting).
Results: For routine revision THA
a dramatic decline of 52% occurred in length of stay over the five
year time span (10.7 days to 5.1 days, p< .001). The average
operative time also declined significantly (238 minutes to 199 minutes,
p< .05) as did the average implant cost (4,349 to 2,827, p<
.001). In spite of this, the average hospital charge increased 16%
(29,666 to 34,328, p< .05). There was a significant and dramatic
35% decline in surgeon reimbursement (3,240 to 2,178, p<001).
There was no significant difference in surgeon reimbursement between
simple, routine and complex THA. Complex cases had significantly
greater LOS (7.3 vs. 5.1 days, p< .05) and operative time (297
vs. 199 minutes). The hospital charge, was dramatically higher for
complex cases (51,290 vs. 34,328) but the surgeon reimbursement
was lower on average, although not statistically significant
(1,926 vs. 2,178).
Discussion and Conclusion: There was
a significant increase in the number and complexity of revision
THAs between the two time periods. Significant decreases were achieved
in LOS, OR time and implant cost. Benefits from these changes were
accrued to the hospital but not the surgeon as hospital charges
increased significantly while surgeon reimbursements declined dramatically.
2:10
Cementless Acetabular Revision at 9-15 Years
Aaron G. Rosenberg, M.D., Laura
Quigley R.N., Joshua J. Jacobs M.D., Rich Berger M.D., Jorge O.
Galante M.D.
We prospectively followed all revisions of cemented
cups from 1983 to 1988. Titanium fiber mesh hemispherical cups were
implanted line to line with supplemental screws. Of 176 hips in
167 patients, 35 died prior to 9 years and 33 had less than 9 year
follow-up (none requiring revision) leaving 106 hips followed an
average of 130 (102-169) months.
87% of cups were radiographically stable and not
revised, however, 7% were radiographically and clinically stable
but required revision for: recurrent dislocation-5, late sepsis-5
and at the time of loose stem revision-2. No revisions for aseptic
loosening were required.
An additional 7 (4%) were possibly unstable (4 of
5 zones with radiolucent lines (RLL) of < 2 mm), while 4 (2%)
were unstable (migration or RLL of > 2mm in 4/5 Zones).
No screw breakage was seen, but at the cup periphery,
separation of the fiber metal pad from the underlying shell was
seen in 2, with pad fragmentation in 11 additional cases (noted
on average at 113 mos.). 2 lucencies were seen about a single screw
and 12 cases demonstrated periacetabular lytic lesions at the component
periphery. These were noted at an average of 118 (59 -166) months.
None have required treatment to date.
2:18
Acetabular Revision
The Role of Rings and Cages
Joseph Schatzker, M.D.
The acetabular roof ring and antiprotrusio cap are
used to protect bone grafts and restore normal acetabular biomechanics.
They depend on press fit and screws for fixation. The polyethylene
cup is cemented into them.
The roof rings are used for small cavitatory defects,
osteoporosis or acetabular dysplasia. The antiprotrusio cages are
used for major cavitatory and segmental defects, pelvic discontinuity
and global acetabular deficiency.
Of 128 patients 95 were revisions. The follow-up
is from 1-16 years with a mean of 6.5 years. 61 patients had ARRings
and 34 patients APCages. Of the revisions 91% were for aseptic loosening,
3% for septic loosening, 3% for broken implants, and 3% for girdlestones.
15% had previous stem and acetabular revisions and 8% previous acetabular
revisions.
At 13 years 14.7% ARRings and 5.8% APCages had failed.
The average pre- and post-operative HHS was 43 and 85 for the ARRings
mid 47 and 83 for the APCages. Evaluation by patients was 76% good
to excellent for the rings and 65% for the cages.
The principle advantage of these devices is the
restoration of normal acetabular biomechanics and the major restoration
of lost acetabular bone.
2:26
Restoration of Bone Stock for
Revision Arthroplasty of the Acetabulum
Allan E. Gross, M.D.
Bone defects on the acetabular side are defined
as contained (cavitary) and uncontained (segmental). Contained (cavitary)
defects can be managed by morsellized allograft bone with an uncemented
cup if contact can be made with 50% host bone. If contact cannot
be made with 50% host bone, we prefer to use a ring and a cemented
cup. Defining success as a stable implant, no further surgery, and
improvement in hip score of at least 20 points, the success rate
was 90% in 50 hips at an average follow-up of 7 years. Segmental
defects involving between 30 to 50% of the acetabulum are managed
by minor column allografts (shelf graft), and a cemented or an uncemented
cup. In 29 hips with an average follow-up of 7 years the success
rate was 86%. Segmental defects involving more than 50% of the acetabulum
are managed by major column allografts. These grafts are fixed by
cancellous screws and protected by a reconstruction ring that extends
from ileum to ischium. In 33 hips with an average follow-up of 7
years, the success rate was 76%.
2:34
Revision Hip Arthroplasty: The Femoral Side
Cecil H. Rorabeck, M.D., James
W. Taylor, M.B., Ch.B.
Total hip arthroplasty has proven to be a highly
successful procedure but with its increased use both in the elderly
and in young high demand patients there is an increase in the numbers
of joints requiring revision. Revision of the femoral component
presents many challenges to the orthopaedic surgeon, including the
necessity for careful preoperative planning, the operative approach,
removal of the failed implant and the cement mantle, the choice
of implants, dealing with bone defects and the management of complications.
We present an outline of our approach to these problems as well
as a review of the literature focusing particularly on the selection
of the prosthesis used, the technique of reconstruction of bone
defects and the classification system used to guide these decisions.
We also present the results of the senior authors' experience with
380 revision hip arthroplasties performed over a 17-year period.
An algorithm for revision of the femoral component, based on this
experience, will be presented suggesting indications for cementless
or cemented fixation and impaction grafting.
2:50
Structural Grafting For Femoral Reconstruction
William C. Head, M.D., Roger H
Emerson, Jr., M.D.,
Theodore I Malinin, M.D.
Structural grafting for femoral reconstruction is
indicated when there is advanced bone loss associated with femoral
prosthetic failure. Total segmental grafts are used when the proximal
femur is severely compromised or totally absent. Cortical onlay
grafts are useful to reconstruct the intact but bone deficient femur.
An alternative to total segmental grafts is a mega-prosthesis for
proximal femoral replacement. Mega-prostheses have higher both early
and late complication rates, and are reserved for sedentary patients
or those patients with a life expectancy of less than 10 years.
The major early complication with a mega-prosthesis is dislocation.
Late complications include dislocation, loosening with associated
osteolysis, breakage of the implant and late infection.
Zehr and Enneking reported a 28% early instability
incidence with mega-prostheses. When a mega-prosthesis is utilized,
a constrained acetabular component is indicated. Primary concerns
related to prosthesis and segmental proximal allograft reconstructions
are dislocation, nonunion and infection. Our current complication
rates are: dislocation, 10%; nonunion, 8% and early infection, 3%.
To date, we have not noted a late infection.
The techniques for total segmental grafts are to
cement the prosthesis into the graft but not into the host bone,
obtain junctional stability and to surround the construction with
as much host bone as possible. The junction should be grafted with
autograft bone.
Onlay grafts are used to supplement the deficient
Type III femur. They cannot be used for primary prosthetic support.
There are attached with circumferential wires with an autograft/allograft
slurry at the interface. They basically unite 100% of the time and
go through the phases of union, revascularization, cancellization,
remodeling and maturation. They do supplement bone stock long term
and perform best when utilized with a proximal load bearing prosthesis.
The histology regarding the two types of grafts is quite different.
Total segmental grafts unite to host bone and then gradually undergo
bone replacement from the junction proximal-ward at a rate of about
1 - 2 millimeters per year. Spotty revascularization occurs over
the outer cortex of the graft via the soft tissue muscle cuff. Problems
of bone resorption have not been noted.
The onlay grafts are rapidly revascularized via
a zone of mesenchymal tissue that grows in at the host/graft interface.
Osteoclasts form cutting cones into the graft. Vascular buds then
invade the graft through these portals and rapid revascularization
takes place.
Both types of grafts are prepared in a freeze-drying
method from the University of Miami Tissue Bank. BMP is retained
in the graft, utilizing this method of preparation and preservation.
There has not been an incidence of disease transmission reported
utilizing freeze-dried bone.
2:58
Twenty Year Experience of Femoral Revision
of Total Hip
Replacement using Second Generation Cementing
Techniques
William T. Wester, M.D., Daniel
M. Estok II, M.D.
and William H. Harris, M.D.
Fifty-seven consecutive, unselected cemented femoral
revisions done in fifty-five patients using second generation femoral
cementing techniques and bead-blasted, monoblock, chrome cobalt
femoral stems were studied prospectively over 20 years. None were
lost to follow-up.
Adverse features were:
- Younger age (average 53 years)
- 24 hips with congenital hip dysplasia or dislocation,
and
- Only one case of femoral stem fracture.
Overall, 14 percent (eight of fifty-seven) were
re-revised for aseptic loosening. Among those with congenital hip
dislocation or dysplasia 21 percent (three of fourteen) were re-revised,
statistically significant (p< .04) more than those without congenital
dysplasia or dislocation (12 percent or five of forty-three).
Among those re-revised, the average time until re-revision
was 14 years. The average age of those re-revised was 42 years at
the index revision, significantly younger than those not re-revised
(59 years). In the entire group over the full 20 years eighteen
of fifty-seven (32 percent) were re-revised or removed.
Second generation femoral cementing led to a re-revision
rate for aseptic loosening over a 20 year span that appears less
than many prior reports.
3:06
Cementless Femoral Revisions
Wayne G. Paprosky, M.D.
The poor results with cemented revision of the femur
with cement techniques led investigators to explore cementless options.
Difficulty in obtaining initial stability in poor quality proximal
bone led to poor intermediate term results. There are currently
no acceptable results of proximally coated stems published in the
literature beyond five years. Fully coated stems bypass the often-deficient
proximal bone and obtain initial diaphyseal fit and stability in
the relatively normal distal bone, allowing for reliable biologic
fixation with the possibility for long term bony ingrowth. There
are several published series at intermediate and long term intervals
with low failure rates. Long term success is dependent on achieving
initial axial and torsional stability by maximizing canal fill at
the time of implantation. This stability can be achieved if there
is at least 4 cm. of intact diaphysis available. Between 1983 and
1988,191 femoral revisions were performed with 171 cases available
for follow-up at ten to sixteen years (mean 13.2). The average age
was 61.2 years (28-85) with 97 females and 73 males. Indications
for revision were 139 cases (82%) for aseptic loosening, fourteen
(8%) for septic loosening, ten (6%) peri-prosthetic fractures and
seven (4%) for malpositioning. Most common stem diameters were 15.0
mm and 16.5 mm. (65%). Femoral bone loss include 11% in Type I femurs,
30% in Type II, 48% in Type 3A and 11% in Type IIIB. According to
ENGH'S stability scales, 82% were bone ingrown, 13.9% were stable
fibrous and 4% were unstable. Stem subsidence occurred in 16% of
cases. All cases with > 90% canal fill were stable. In Type 3B
cases, 21% proved to be unstable. There was 21% proximal osteolysis
and 6% severe stress shielding occurring only in DORR Type C bone.
Clinical results using D'Aubigne and Postel scales showed pain improvement
from 2.6 to 5.6 and overall 5.6 to 10.8.
Complications were as follows: Intra-op fractures,
8.9%, dislocations, 6.8%, infections, 2% and sciatic nerve injuries,
2%. Overall, these results at a mean of 13.2 years are very encouraging
for the prospects of long term success.
3:50
THA in Special Cases -DDH
William N. Capello, M.D., Yuichi
Itoh M.D., Judy Feinberg, Ph.D.
Developmental dysplasia of the hip (DDH) poses a
number of technical challenges for the arthroplasty surgeon. The
femur is often excessively anteverted and the canal narrow. The
anatomic acetabulum may be rudimentary, and bone quality on both
sides may be poor. The goals of THA in DDH include:
- Anatomic placement of the acetabular component.
- Shortening and derotation of the femur, and
- Creation of an offset to promote a limp-free
gait.
Restoration of leg length is not a goal of the reconstruction.
Femoral transection and removal of an intercallary
section of the femur has advantages over other approaches. These
advantages include:
- Retention of the abductor mechanism.
- Multiple prosthetic options on the femoral
side.
- Improved mechanics, and
- Excellent acetabular exposure.
By decompressing the femur the likelihood of nerve
damage is minimized. A potential disadvantage of this approach is
a delayed or nonunion of the osteotomy site.
Our experience includes 26 hips in 20 patients.
A transverse femoral osteotomy was used in 18 cases (oblique in
the other 8). Stem fixation included 12 proximally coated, 11 extensively
coated and 3 cemented. Average follow-up is 50 months (range, 13
to 104). No stems and three cups have been revised (2 for aseptic
loosening, 1 post-fracture). Complications include two hips with
osteotomy nonunion and one hip with a femoral nerve injury. Clinically
96% are pain-free. A mild limp only is noted in about one-half of
the cases.
Based on our experience to date, we believe that
the transfemoral approach to THA in DDH is a versatile approach
to a difficult problem. We currently recommend the use of the transverse
osteotomy in conjunction with an extensively fixed cementless implant
(either monoblock or modular) to secure the osteotomy site on the
femoral side.
3:58
Single-Stage Bilateral Total Hip Arthroplasty
William Macaulay, M.D., Eduardo
A. Salvati, M.D.,
Thomas P. Sculco, M.D., and Paul
Pellicci, M.D.
This work reviews the current knowledge and literature
with regard to bilateral total hip arthroplasty (THA) performed
during a single stage. Special emphasis is placed on the Hospital
for Special Surgery experience over three decades. Relative indications,
contraindications, techniques and anticipated complications for
the surgery are reviewed. The main conclusion is that single-staged
bilateral total hip arthroplasty is a viable option for the motivated
patient with few medical comorbid conditions. The decision to undergo
single-stage THA must be arrived at by the patient with agreement
and consultation of the physicians involved.
4:06
Total Hip Arthroplasty in Paget's Disease
David G. Lewallen, M.D.
Paget's disease is a localized disorder of bone
marked by increased bone turnover. With a probable viral etiology,
the disease is marked by increased resorption and formation with
monostotic and polyostotic patterns possible. The pelvis and upper
femur are involved in 20-80 percent of patients with Paget's disease.
This fact, combined with a disease incidence that rises with age
from approximately 5 percent of those over 40 to as high as 15 percent
of the elderly, leads to a not infrequent association with disabling
hip pathology and hip arthroplasty. Serum alkaline phosphatase is
elevated due to increased bone resorption with elevated urine hydroxyproline
caused by the breakdown of type I collagen in bone. With progression,
the characteristic radiographic features emerge with mixed sclerosis
and adjacent osteoporosis and coarse and irregular trabeculae. The
altered mechanical properties caused by these pagetoid changes can
lead to enlargement of the involved bone, thickened cortices, and
bone deformities: varus bowing of the femur, coxa vara, and acetabular
protrusio. Subcapital fractures and nonunions, along with stress
fractures of the proximal femur, can complicate management. It is
unclear whether osteoarthritis is any more common in Paget's disease
than in age-matched controls, but the pattern of involvement and
wear of the joint can be altered. Atypical destructive bone changes
superimposed on typical pagetoid patterns should suggest the possibility
of sarcomatous change. Technical challenges imposed by the disease
can range from minor to extremely complex and can involve the need
for special implants and simultaneous femoral osteotomy. Careful
preoperative assessment and appropriate medical management are important
in order to optimize outcome. If arthroplasty is indicated, preoperative
planning and preparation of any needed equipment and implants is
very important. Total hip arthroplasty is highly successful in the
management of patients with Paget's disease, with reported results
of conventional cemented arthroplasty similar to, though slightly
less durable than, those seen in routine cemented total hip arthroplasty
populations. The potential value of uncemented acetabular fixation
and extensively porous-coated uncemented femoral implants in the
management of patients with Paget's disease requiring total hip
arthroplasty remains to be established with long-term follow-up
data needed.
4:14
Primary and Revision Total Hip Replacements
in Jehovah's Witnesses
Carl L. Nelson, M.D.
The concept of performing elective primary or revision
total hip replacement arthroplasties without the option of allogeneic
transfusion is controversial. However, there are studies showing
that elective reconstructive surgery can be done in Jehovah's Witnesses
without the use of allogeneic transfusion and without a high rate
of complications related to blood loss.
The strategies that are used include meticulous
hemostatis, preplanned surgery, intraoperative autotransfusion (in
some cases), hypotensive anesthesia, and erythropoietin therapy.
The challenge is to determine the best blood management strategies
to implement for the individual patient.
It is essential to understand the importance of
blood volume and have the ability to calculate the patient's blood
volume when one chooses to do elective surgery without the use of
allogeneic transfusion. The volume of blood loss that can be tolerated
in any surgical setting is directly related to the initial total
blood volume. A simplified calculation assumes that males have approximately
65 to 75 mL of blood per kilogram of body weight and because females
typically have more adipose tissue than males, it is estimated that
females have approximately 55 to 65 mL of blood per kilogram (kg)
of body weight.
The ability to predict tolerable perioperative blood
loss is an important step in planning a blood management strategy.
It is important to determine the lowest safe level of hematocrit
(HCT) the individual patient can tolerate. After establishing the
lowest acceptable limit for postoperative HCT, the estimated blood
loss (EBL) that can occur without reducing the postoperative HCT
below that established limit can be calculated:
EBL = VOL x (HCTpre - HCTpost)
HCTpre
Where EBL = Estimated blood loss
VOL = Total blood volume
HCTpre = Preoperative hematocrit
HCTpost = Postoperative hematocrit
This equation was used to derive the plots in Figures
1 and 2 and are based on postoperative HCT levels of 21% and 30%,
respectively. Each plot represents an estimate of the volume of
blood that can be lost in 100 kg, 70 kg, and 50 kg individuals without
breaching the lower postoperative HCT limit of 21% and 30%, and
includes the range of values that would result from calculating
total blood volumes for lean and obese males and females. The solid
line within each range represents the average of the range.
Once the amount of tolerable blood loss that can
occur during the perioperative period is determined, the surgeon
then must estimate the amount of blood loss that will occur during
surgery and in the perioperative period. If the estimated blood
loss is greater than the calculated tolerable blood loss, then strategies
may be used to decrease red blood cell loss or increase red blood
cell mass.
In any operative procedure, careful surgical
dissection with precise hemostasis is one of the most effective
ways to minimize surgical blood loss and reduce the need for allogeneic
red blood cell transfusion. Clearly, the combination of operative
technique and hypotensive anesthesia is cumulative and synergistic
and good surgical technique is essential to reap the full benefit
of hypotensive anesthesia. A well-planned surgical procedure that
progresses step-by-step in a controlled, efficient manner effectively
reduces the amount of time spent and the amount of blood loss.
In eighty-nine patients who were Jehovah's Witnesses
who underwent total hip replacement arthroplasty without transfusions
were performed under hypotensive anesthesia with modified surgical
technique. There was a 43 percent reduction in blood loss compared
to matched controls. There were no complications related to blood
loss.
Jehovah's Witnesses who require revision total hip
replacement arthroplasty can be successfully managed by the use
of hypotensive anesthesia, modified surgical technique and the use
of erythropoietin. In five Jehovah's Witnesses undergoing revision
total hip replacement arthroplasty received preoperative recombinant
erythropoietin. The average hematocrit was 39.5 percent before therapy
and 47.6 after therapy and before the operation. The average hematocrit
was 36.8 percent immediately after the operation and 30.8 percent
at the time of discharge. The use of erythropoietin preoperatively
is particularly suited for revision joint replacement surgery because
of the elective nature and the moderately flexible timing associated
with the procedure and provides for the Jehovah's Witness an increased
red cell mass and an increased margin of safety.
The graphs provide an easy way to determine the
red blood cell requirement to maintain hematocrits of 21 or 30%.
With reliable estimates of total blood volume and expected blood
loss, predictions about the need to blood management strategy can
be made with more accuracy. The techniques used in Jehovah's Witness
patients have included erythropoietin therapy, hypotensive anesthesia,
meticulous hemostasis and on occasion, intraoperative blood cell
salvage. When the margin of safe blood loss is anticipated, the
most appropriate blood conservation options can be implemented perioperative
blood management optimized.
Fig. 1 Fig. 2
The range of estimated blood loss (mL) for male
and female patients to maintain
a postoperative hematocrit of 21% -30% calculated
according to
EBL = VOL x (HCTpre - HCTpost)
HCTpre
Dot = 50-kg patients; slash = 70-kg patients; and
lined = 100-kg patients.
Instructions for using graph:
- Determine the weight in kilograms, hematocrit
percent, and the gender of the patient.
- Identify the appropriate point on the graph.
- The upper limit of this range of allowable blood
loss is for a lean male and the lower limit is for an overweight
female.
- If the expected blood loss exceeds the allowable
blood loss, compensatory methods to reduce the loss of red blood
cell mass or to increase red blood cell mass need to be instituted.
4:22
Total Hip Arthroplasty for Hip Fractures
M. E. Cabanela, M.D.
At present in this country the majority of displaced
femoral neck fractures in patients older than 65 years is handled
by arthroplasty. The vast majority of the patients are treated by
hemiarthroplasty and a small number by total hip replacement. Although
one can find literature support for any kind of therapeutic attitude,
the general trend is to utilize uncemented unipolar prostheses in
very elderly patients with expected short survival and poor ambulatory
status; patients with an active lifestyle, estimated good survival
and no other health problems are treated with cemented bipolar prostheses,
or in some centers cemented unipolar prosthesis (primarily for cost
reasons); total hip replacement is usually reserved today for patients
who have hip disease predating their femoral neck fracture.
However, some trends appear to be developing towards
use of total hip replacement in active patients over the age of
65 and a strong case could be made for this treatment philosophy
based on the information available from the literature. Against
the use of hemiarthroplasty in active individuals are the known
facts of persistent groin pain and acetabular erosion that may necessitate
conversion to a hip replacement arthroplasty. This has been reported
both with unipolar and bipolar prostheses, less frequently with
the latter, while it is infrequent with total hip arthroplasty.
Several studies have reported good results with
total hip replacement for femoral neck fractures. Lower revision
rates, higher functional scores and better pain relief are common
with total hip replacement. However, a significantly higher number
of early postoperative complications including dislocation have
been reported. These complications, particularly dislocations, seem
to occur within the first 3-4 months after the replacement and not
later. Our own experience with hip replacement for femoral neck
fractures was reported by Lee et al and showed a remarkable prosthesis
survivorship of 95% at five, 94% at 10, 89% at 15, and 84% at 20
years in 126 patients with an average age of 75 years. Furthermore,
two prospective studies comparing hemiarthroplasty and total hip
arthroplasty show better results with total hip arthroplasty with
follow-ups of six months to one year and the mortality was similar
in both treatment groups.
It would appear then that cost issues aside, total
hip arthroplasty can be considered as a reasonable and even desirable
treatment alternative in patients with displaced femoral neck fractures,
particularly those healthy and active. Exquisite attention to technical
detail and careful repair of the soft tissues may help diminish
the main problem with total hip replacement in this setting, namely
that of postoperative dislocation. For the very elderly patient
with low physical demands and poor health, hemiarthroplasty is a
faster and more predictable treatment alternative.
4:30
Total Hip Arthroplasty in Patients
with Proximal Femoral Deformity
Daniel J. Berry, M.D.
Most proximal femoral deformities encountered during
hip arthroplasty are secondary to developmental processes, previous
osteotomy or fracture. Deformities may be categorized anatomically
by level and geometry. Anatomic levels include femoral neck deformities,
metaphyseal deformities, metaphyseal-diaphyseal junction deformities
and diaphyseal deformities. Deformities at each level may be angular
(varus, valgus, flexion, extension), rotational or translational
or a combination thereof.
Treatment is individualized according to patient
needs and anatomic demands of the deformity. Careful preoperative
planning is essential. If cemented implants are used, care must
be taken to obtain reasonable alignment and a continuous cement
mantle. For uncemented implants, obtaining a good fit is more challenging
and risk of intraoperative fracture is elevated. Access to a wide
range of implants helps the surgeon manage unique femoral geometries.
Implants fixed in the diaphysis allow some proximal femoral deformities
to be bypassed. Modular or custom implants simplify management of
certain deformities.
For severe deformities femoral osteotomy may be
required. Successful osteo-tomy requires deformity correction, maintaining
vascular supply of fragments, obtaining fixation of osteotomy fragments
(with the implant or adjunctive fixation) and obtaining implant
stability. Though most deformities can be managed during hip arthroplasty,
occasionally there is a role for two-stage management: deformity
correction followed later by arthroplasty.
|